CME/CE/CPE Slide Presentations

NSAIDS in the Treatment of Acute Pain: A Look at Safety, Tolerance and Efficacy

Author
Steven M. Simon, M.D., R.Ph.
Clinical Assistant Professor
Department of Physical Medicine and Rehabilitation
University of Kansas Medical Center
Clinical Assistant Professor, Kansas City University of Medicine and Biosciences
Department of Family Practice
Kansas City, Missouri

Statement of Need
Nonsteroidal anti-inflammatory drugs (NSAIDs) are often used to treat musculo-skeletal disorders and other conditions involving pain. While efficacious, concerns have arisen about the risks of significant upper gastrointestinal tract injury with use of these drugs. Newer agents have been associated with lower rates of gastrointestinal complications.

Physicians, pharmacists and nurses play a key role in the diagnosis and management of pain. Central to that responsibility is a current understanding of the key issues and factors involved in optimizing pharmacologic treatment, which this program seeks to address.

Intended Audience
This program is intended for physicians, nurses, pharmacists, and other associated healthcare professionals who care for patients experiencing acute or chronic pain.

Learning Objectives
Upon completion of this activity, the participant should be able to:

1. Discuss the diagnosis and etiology of acute pain.
2. Discuss the need to explore comorbid issues and safety concerns.
3. Describe the management of acute pain from the basis of evidence-based medicine.
4. Describe the physical symptoms and the most cost appropriate treatment options.

Disclosures
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), the Dannemiller Memorial Educational Foundation requires that any person who is in a position to control the content of a CME activity must disclose all relevant financial relationships they have with a commercial interest. Accordingly,

Steven M. Simon, MD has disclosed the following: Dr. Simon is a speaker for Pfizer, Eli Lilly, Acorda, King Pharmaceuticals, Alpharma, Sanofi, Sepracor, and Cephalon. His spouse has received research grants from Pfizer and Cephalon.

Mary Brady Service, medical writer/editor discloses that she has no financial relationships with any commercial interests that are relevant to this activity.

The Dannemiller Memorial Educational Foundation staff that was involved in the development of this activity has no financial relationships with any commercial interests that are relevant to this activity.

To resolve identified conflicts of interest, the educational content was fully reviewed by a physician member of the Dannemiller Clinical Content Review Committee who has nothing to disclose. The resulting certified activity was found to provide educational content that is current, evidence based and commercially balanced.

Off-label statement
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Disclaimer
The contents and views presented in this educational activity are those of the authors and do not necessarily reflect those of the Dannemiller Memorial Educational Foundation or Victory Pharma. This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject matter before relying solely upon the information contained within this educational activity.

For questions regarding the content of this activity and technical assistance, contact Dannemiller Memorial Educational Foundation, accredited provider for this CME activity, at editor@dannemiller.com.